The price of a box of Ameditinib usually ranges from $2,000 to $4,000. The price is affected by factors such as hospital grade, reimbursement rate and production specifications, so there are some differences. Aimitinib, known as Aimitinib Mesylate Tablets, is mainly indicated for the treatment of adult patients with locally advanced or metastatic non-small cell lung cancer who have experienced disease progression during or after previous treatment with epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) and have been confirmed to be positive for the EGFR T790M mutation. Ameditinib also has certain side effects, which can include pruritus, hepatic impairment, abnormal heart rhythms, hyponatremia, and proteinuria. It is also contraindicated for those who are allergic to the product and for those who are preparing for pregnancy, pregnant patients, or breastfeeding. Amitinib should be used under the guidance of a professional physician, do not self-medicate to avoid serious adverse reactions or delays in the condition.